Who Should Avoid Ketamine Therapy? Contraindications Explained

If you have uncontrolled severe hypertension, an aneurysm or recent intracerebral hemorrhage, active psychosis or a current manic episode, or you are pregnant or breastfeeding, ketamine therapy is off the table for you right now. Severe, unstable coronary artery disease and known hypersensitivity to ketamine or esketamine belong on that same list. These are the absolute contraindications, the ones no reputable clinician will negotiate around, and if any of them apply to you, the answer is no, not yet, maybe never.

Most other risk factors are not absolute. High blood pressure that is well controlled, a distant psychiatric history, a stabilizing substance use disorder, or liver disease that is monitored rather than advanced usually fall into a different category: relative contraindications that require closer review, not automatic rejection.

• Absolute: uncontrolled hypertension, aneurysmal vascular disease, active psychosis, pregnancy/breastfeeding, unstable coronary disease, known hypersensitivity
• Relative: controlled hypertension, remote psychosis history, active substance use disorder, liver dysfunction, seizure history

Pro Tip: Don’t try to self-diagnose your eligibility from a blog post, even this one. Bring your full medication list and cardiac history to your intake appointment and let a clinician screen you properly.

The SPRAVATO prescribing information reports that 3% to 19% of patients had a significant blood pressure spike within the first 90 minutes of dosing during the first month of treatment, which is exactly why cardiovascular screening comes first, not last. If you recognize yourself in any of the absolute categories above, stop here and call your prescriber or a clinic intake line before you do anything else. Do not attempt to self-administer ketamine from an unsupervised source to “test” your tolerance. That’s a separate and much more dangerous problem.

Key Takeaways

Ketamine therapy is safe for most carefully screened patients, but absolute contraindications like uncontrolled hypertension, active psychosis, and pregnancy require ruling out before any treatment begins.

Table of Contents

• Why Ketamine Therapy Contraindications Exist in the First Place
• What Are the Absolute Contraindications to Ketamine?
• Which Conditions Are Only Relative Contraindications?
• What Screening and Tests Should You Expect Before Treatment?
• Can You Become Eligible if You’re Currently a Borderline Candidate?
• What Should You Do If You’re Ruled Ineligible for Ketamine?
• How Is Your Safety Monitored During and After a Ketamine Session?
• How Mystic Health Approaches Screening and Safety
• Does Bipolar Disorder or a Personality Disorder Rule You Out?
• Which Medications Can Interact Dangerously With Ketamine?
• Are There Age-Related Restrictions for Ketamine Therapy?
• How Do Clinics Handle Complex, Overlapping Risk Factors?
• What Actually Matters Most in This Conversation
• Ready to Find Out If Ketamine Therapy Is Right for You?
• Frequently Asked Questions
• Sources

Why Ketamine Therapy Contraindications Exist in the First Place

Ketamine works differently depending on the dose, and that difference is the whole story behind why contraindications exist at all. At subanesthetic, therapeutic doses, ketamine acts primarily as an NMDA receptor antagonist that produces mild dissociation and, over a course of sessions, measurable antidepressant effects. At higher, anesthetic doses, or with chronic uncontrolled use, the same drug behaves very differently in the body, and that gap between “therapeutic” and “anesthetic or recreational” is where most safety rules originate.

Ketamine is a sympathomimetic, meaning it tends to raise heart rate and blood pressure rather than lower them. For most healthy people that’s a manageable, transient bump. For someone with an existing aneurysm, unstable coronary disease, or blood pressure that’s already poorly controlled, that same bump can be the difference between a routine session and a medical emergency. This is precisely why StatPearls lists conditions like aortic dissection risk and uncontrolled hypertension as contraindications.

Two other mechanisms matter, though they get less attention:

• Liver metabolism: ketamine is processed hepatically, and while rare, hepatotoxicity has been documented, which is why baseline liver function testing matters for anyone with existing liver disease.
• Urothelial and hepatobiliary risk: these complications show up almost exclusively with chronic, high-frequency, high-dose recreational use, not with the infrequent, supervised, sub-anesthetic dosing used in clinical therapy, according to the same StatPearls review.

Supervised, infrequent, lower-dose administration doesn’t eliminate every risk, but it changes the risk profile substantially compared to unsupervised or heavy recreational use.

What Are the Absolute Contraindications to Ketamine?

An absolute contraindication means a clinician will decline treatment, full stop, regardless of how much you want the therapy or how promising it might be for your particular symptoms. These aren’t judgment calls. They’re conditions where the physiologic or psychiatric risk of ketamine outweighs any plausible benefit.

1. Uncontrolled severe hypertension. If your blood pressure runs consistently high despite treatment, or you’ve never had it properly managed, ketamine’s tendency to spike systolic and diastolic pressure creates a real risk of hypertensive crisis, stroke, or cardiac strain. Clinics typically want documented, stable readings before they’ll even schedule an intake, not just a single good number on the day of your appointment.

2. Aneurysmal vascular disease or recent intracerebral hemorrhage. This is one of the clearest absolute exclusions in the SPRAVATO label itself. If you have a known aneurysm anywhere in your vascular system, or you’ve had a recent bleed in the brain, the blood pressure elevation that ketamine can cause isn’t a minor side effect. It’s a mechanism that can turn a stable aneurysm into a ruptured one.

3. Active psychosis, schizophrenia, or a current manic episode. Ketamine’s dissociative properties can worsen psychotic symptoms in someone actively experiencing them. This isn’t about people who’ve had psychosis in the past and are stable now (that’s a different, relative category covered below). It’s about active, unmanaged psychotic or manic states where dissociation is the last thing that person’s nervous system needs.

4. Pregnancy and breastfeeding. StatPearls is direct on this point: ketamine isn’t recommended during pregnancy or lactation because of embryo-fetal and neonatal safety concerns that haven’t been adequately studied. If you’re pregnant, trying to conceive, or nursing, this conversation needs to happen with your obstetric provider before it happens with a ketamine clinic.

5. Severe, unstable coronary artery disease, recent heart attack, or decompensated heart failure. A heart that’s already working under strain doesn’t need the added cardiac demand of ketamine’s sympathomimetic effects layered on top. This is a cardiology-first conversation, not a mental health intake question.

6. Known hypersensitivity to ketamine or esketamine. If you’ve had an allergic reaction to either compound before, that’s a straightforward and permanent exclusion.

None of these are conditions a clinic can “work around” with extra monitoring. They represent the line between a manageable risk and an unacceptable one, and any provider worth trusting will tell you that plainly rather than trying to find a workaround.

Which Conditions Are Only Relative Contraindications?

This is where the nuance lives, and it’s also where a lot of people wrongly assume they’re disqualified when they’re actually still candidates under the right conditions. A relative contraindication means the condition raises risk, but it can often be mitigated, monitored, or optimized so treatment becomes safe rather than dangerous.

Hypertension that’s controlled versus uncontrolled is the clearest example. Someone on medication with consistently normal readings is treated very differently from someone whose blood pressure runs high unpredictably. Clinics commonly set an on-day threshold, deferring treatment if your blood pressure reads too high that morning even if your baseline control has been fine, and may ask you to adjust medication timing under your physician’s direction.

A history of psychosis doesn’t automatically close the door. Clinicians distinguish between a distant, well-managed episode and an active or recent one. Someone with a remote history who has been stable for years under psychiatric care may still be eligible, but this decision usually requires an actual psychiatry consult, not a guess based on a checkbox in an intake form.

Active or recent substance use disorder falls into this category too, though clinics vary in how strict they are. Because ketamine carries its own misuse potential, and because co-occurring substance use raises the risk of adverse interactions, most reputable protocols require some period of stabilization and a structured screening process before considering someone a candidate. Understanding ketamine tolerance and how the body adapts to repeated dosing matters here too, since a history of frequent recreational use changes the risk calculation.

Liver disease typically means baseline liver function tests before starting, plus periodic monitoring throughout a treatment course, rather than an outright bar. The severity of the underlying liver condition determines how cautious the plan needs to be.

Seizure history, significant cognitive impairment, and advanced age or frailty round out the list. None of these are disqualifying on their own, but they push a clinic toward more conservative dosing, closer monitoring, and sometimes a formal anesthesia-style risk classification (similar to ASA physical status categories used before surgery) to decide how cautiously to proceed.

Pro Tip: If you fall into a relative category, ask your intake coordinator directly what “optimized” looks like in your case. A vague “we’ll see” answer is a red flag. A specific plan (BP targets, lab recheck intervals, psychiatry sign off) is what a well-run program should offer.

What Screening and Tests Should You Expect Before Treatment?

Before anyone puts a needle in your arm or a spray in your nose, a competent clinic runs through a structured checklist. Knowing what’s coming ahead of time makes the process feel less like an interrogation and more like what it actually is: a safety net built for your benefit.

1. Vitals, checked more than once. Blood pressure and heart rate get measured at intake and again on the day of treatment. Many clinics rely on home blood pressure logs in the weeks leading up to your first session, and a markedly elevated reading on the day itself, even in someone with generally good control, commonly triggers a deferral rather than a risk.
2. A focused medical and psychiatric history review. This isn’t a generic form. Expect specific questions about cardiovascular events, aneurysm history, psychosis, mania, substance use, liver problems, seizures, and pregnancy status.
3. Baseline labs and tests. Standard components include an ECG, a complete blood count and basic metabolic panel, liver function tests, a urine drug screen, and a pregnancy test where applicable.
4. Specialist clearance when indicated. If your history includes significant heart disease, liver dysfunction, an active substance use disorder, or a complicated psychiatric picture, expect a referral to cardiology, hepatology, addiction medicine, or psychiatry before treatment is approved.

The rationale behind each step traces back to the same physiology discussed earlier: transient dissociative and blood pressure effects that typically peak around 30 minutes after IV dosing and resolve within roughly an hour, according to a peer-reviewed review of IV ketamine safety. Screening exists to catch the people for whom that predictable window of physiologic stress isn’t predictable at all. A patient’s guide to what happens at a ketamine clinic can walk you through what a typical intake visit looks like in more detail.

• Bring a current medication list, including supplements
• Bring recent blood pressure readings if you track them at home
• Be ready to discuss substance use honestly. Withholding this information doesn’t protect you, it removes a safeguard

Can You Become Eligible if You’re Currently a Borderline Candidate?

Yes, in many cases, and this is the part of the conversation that gets buried under all the caution above. A relative contraindication is, by definition, something that can sometimes be changed.

If blood pressure is the issue, work with your physician on medication adjustment and give it time to show consistent control before your intake, not just a lucky reading on the morning of your appointment. If an active substance use disorder is the barrier, stabilization through appropriate treatment, not willpower alone, is what most programs require before reconsidering candidacy. If a reversible medical issue is flagged during screening, whether that’s a lab abnormality or an unmanaged condition, getting specialist clearance often reopens the door.

• Get blood pressure under documented, consistent control with your prescribing physician
• Complete substance use stabilization through a structured program before re-applying
• Correct reversible lab abnormalities and obtain the specialist sign off your intake team requests
• Talk through contraception and breastfeeding plans openly with your provider if either applies
• Review your full medication list with a clinician, since some temporary adjustments may be needed under supervision, never on your own

Pro Tip: If a clinic defers you, ask specifically what would need to change for reconsideration and roughly when to check back in. “Not eligible right now” and “not eligible ever” are very different answers, and a good program will tell you which one applies.

What Should You Do If You’re Ruled Ineligible for Ketamine?

Being told you’re not a candidate right now isn’t a dead end, but it does mean the path forward has to run through your clinician, not around them. Safe alternatives exist, and pursuing them properly protects both your health and your future eligibility.

Depending on what disqualified you, reasonable next steps might include adjusting your existing psychiatric medication regimen with your prescriber, engaging more intensively in psychotherapy, or exploring other evidence-based approaches such as neuromodulation, where clinically appropriate. None of these are lesser options. They’re simply different tools that may fit your specific medical picture better right now.

• Ask for a referral to the specialist most relevant to your disqualifying condition (cardiology, psychiatry, addiction medicine, or hepatology)
• Request a clear timeline for re-evaluation once the underlying issue is addressed
• Keep a record of lab results and specialist clearances so re-screening goes faster next time
• Avoid unsupervised or recreational ketamine use entirely. It carries the same physiologic risks that disqualified you from supervised treatment, minus every safeguard that makes clinical ketamine therapy safer

Re-assessment timing varies by condition. Blood pressure control might be reconfirmed in a matter of weeks with consistent readings, while substance use stabilization or major cardiac events typically require a longer, specialist-guided timeline before anyone revisits your candidacy.

How Is Your Safety Monitored During and After a Ketamine Session?

The screening process is only half the safety picture. What happens in the room during your actual session matters just as much, and it’s worth knowing what to expect so you can ask informed questions before you commit to a provider.

1. Vitals monitoring runs continuously. Blood pressure and heart rate get checked before dosing, at intervals during the session, and again afterward. Because effects typically peak around 30 minutes into an IV session and resolve within about an hour, per the PMC review on IV ketamine safety, that window is when monitoring is most intensive.
2. You’ll stay for a defined observation period after dosing, and that window gets extended if your vitals or your dissociative response haven’t settled to baseline.
3. Staff should be trained for emergencies, ideally with ACLS certification and resuscitation equipment on site, consistent with the monitoring standards described in clinical guideline literature on esketamine and ketamine for depression.
4. You won’t be allowed to drive yourself home, and most programs restrict driving until the following day given residual dissociative effects.

Most people experience only transient effects, dizziness, mild nausea, brief dissociation, resolving within one to two hours according to Cleveland Clinic’s overview of ketamine therapy. If something doesn’t resolve on that expected timeline, or your blood pressure spikes beyond your clinic’s threshold, a well-run program will stop the infusion and manage you accordingly rather than pushing through the session as planned.

How Mystic Health Approaches Screening and Safety

Every point covered above translates into practice at Mystic Health, where integrative psychedelic therapy, ketamine-assisted psychotherapy, and Spravato are offered under personalized, safety-first treatment plans rather than a one-size-fits-all protocol.

Screening isn’t a formality here. It’s the foundation that determines whether ketamine-assisted therapy is the right tool for your specific medical and psychiatric picture, and if it isn’t, we say so and help you find what is.

• Personalized treatment plans built around your actual medical and psychiatric history, not a generic intake script
• Support navigating insurance compatibility and financing options so cost isn’t a barrier to proper screening
• Access to clinical evidence resources that explain the reasoning behind absolute and relative contraindications in plain language

If you’re unsure where you fall on the eligibility spectrum, that uncertainty is exactly what an intake conversation with a qualified provider is meant to resolve, not something you should try to sort out alone.

Does Bipolar Disorder or a Personality Disorder Rule You Out?

Psychosis gets most of the attention in contraindication discussions, but bipolar disorder and severe personality disorders deserve their own conversation, and the answer is more nuanced than a flat yes or no.

Ketamine can, in some cases, trigger or worsen manic symptoms in people with bipolar disorder, which is why a current or recent manic episode functions as an absolute exclusion similar to active psychosis. A history of bipolar disorder that is currently stable and well managed is typically treated as a relative contraindication rather than an absolute one, but it demands a careful psychiatric review before treatment starts, often including a look at your current mood stabilizer regimen and recent mood history.

Severe personality disorders, particularly those involving significant dissociative symptoms, impulsivity, or unstable identity, raise a different concern. Ketamine’s dissociative effects can be disorienting even for psychiatrically stable people, and for someone whose baseline includes dissociative or identity disturbances, that effect can be harder to distinguish from a worsening of their underlying condition. This doesn’t automatically disqualify someone, but it does mean a more thorough psychiatric consultation and, often, closer in-session support than a standard candidate would need.

The common thread across both conditions is the same principle covered earlier: it’s not the diagnosis alone that determines eligibility, it’s how stable and well managed that diagnosis currently is, and whether a psychiatrist familiar with your case has weighed in directly.

Which Medications Can Interact Dangerously With Ketamine?

Your medication list matters just as much as your diagnosis list, and this is a step people underestimate constantly. Certain drug combinations don’t just reduce ketamine’s effectiveness, they actively raise your risk during treatment.

Sedatives, benzodiazepines, and opioids can compound ketamine’s dissociative and sedative effects unpredictably, which is part of why Cleveland Clinic advises avoiding alcohol, cannabis, and sedative opioids on treatment days specifically. Stimulant medications or substances can amplify the sympathomimetic blood pressure effects discussed earlier, which becomes a real concern for anyone already flagged as a relative cardiovascular risk. Certain psychiatric medications, particularly some MAOIs and specific mood stabilizers, require careful review by your prescribing psychiatrist before a ketamine course begins, since interactions vary by drug class and individual regimen.

This is precisely why medication reconciliation is a standard part of intake rather than an afterthought. Bring your complete list, including over-the-counter medications and supplements, because something as ordinary-seeming as a sleep aid or an herbal supplement can matter more than you’d expect. Never assume a medication is “probably fine” to combine with ketamine without a clinician actually checking. That’s a decision for your prescriber, not a guess made the morning of your appointment.

Are There Age-Related Restrictions for Ketamine Therapy?

Age extremes change the risk calculation in ways that are worth understanding before you assume ketamine therapy is or isn’t an option for you or a family member.

On the pediatric end, ketamine therapy for depression and related conditions is not an established treatment path for children and adolescents outside of very specific, specialized clinical contexts, and most outpatient psychedelic therapy clinics, including programs built around adult mental health care, don’t treat minors for these indications. If you’re exploring options for a younger person, that conversation needs to happen with a pediatric specialist, not a general ketamine clinic.

On the other end, elderly patients aren’t automatically excluded, but age brings a higher likelihood of the exact comorbidities that turn into relative or absolute contraindications: cardiovascular disease, polypharmacy, cognitive impairment, and general frailty. This is where anesthesia-style risk classification systems become genuinely useful tools, helping a clinical team weigh overall physiologic reserve rather than treating age itself as the disqualifying factor. An otherwise healthy 70 year old with well-controlled blood pressure and no cognitive concerns may be a perfectly reasonable candidate, while a 55 year old with poorly managed cardiac disease may not be.

The takeaway isn’t that age alone determines eligibility. It’s that age correlates with the kinds of medical complexity that make thorough screening even more important, not less.

How Do Clinics Handle Complex, Overlapping Risk Factors?

Real patients rarely show up with a single, clean contraindication. More often, it’s a combination: controlled hypertension plus a remote psychiatric history, or mild liver dysfunction plus a medication that needs review. This is where good clinical judgment matters more than any checklist.

The right approach isn’t to tally risk factors and reject anyone who has more than one. It’s to look at how each factor interacts with the others and whether the combination changes the overall risk profile meaningfully. Someone with well-controlled hypertension and no other risk factors might be a straightforward candidate, but add a remote psychosis history and a benzodiazepine prescription to that picture, and suddenly you need input from both cardiology and psychiatry, plus a careful medication review, before anyone can make a responsible decision.

This is also where multidisciplinary coordination earns its keep. Complex cases often benefit from a treatment team that includes your ketamine provider, your primary care physician, and any relevant specialist, all communicating rather than working in isolation. If a clinic seems willing to wave you through despite multiple overlapping risk factors without involving your other providers, treat that as a warning sign rather than reassurance. The safest programs tend to be the ones most willing to slow down, ask more questions, and coordinate before saying yes.

What Actually Matters Most in This Conversation

The conventional advice on ketamine contraindications tends to bury the useful information under a wall of medical caution, and that’s a disservice to people trying to make a real decision about their own care. The research supports a clearer message: most people who ask about ketamine therapy are not automatically excluded. They’re relative candidates who need a proper workup, not a rejection.

What’s overrated is the fear that any psychiatric history or any cardiovascular risk factor is an automatic disqualifier. It usually isn’t. What’s underrated is how much a controlled, well-documented condition, whether that’s blood pressure or a stabilized substance use history, can shift you from “not a candidate” to “a candidate under monitored conditions.”

If you take one thing from this article, let it be this: don’t self-select out based on a rumor or a worst-case story you read somewhere. Get screened by a clinician who actually distinguishes between absolute and relative risk, and let the data on your specific case, not a general checklist, make the call.

Ready to Find Out If Ketamine Therapy Is Right for You?

Reading through contraindications on your own only gets you so far. What actually determines your eligibility is a real screening conversation with a clinician who knows how to weigh your specific history, not a checklist. Mystic Health builds that process around you: a personalized intake that reviews your cardiovascular history, psychiatric background, and current medications before anyone talks about treatment plans, backed by insurance compatibility and financing support so cost isn’t what decides whether you get screened at all.

If any part of your history feels ambiguous, uncontrolled blood pressure that’s improving, a psychiatric history that’s been stable for years, a liver condition you’re managing, that’s exactly the kind of case a proper intake is built to sort through. Visit Mystic Health’s program overview to see how ketamine-assisted psychotherapy and Spravato fit into a broader integrative mental health plan, or head to the integrative mental health page to schedule your evaluation and get a clear, individualized answer instead of guessing from a blog post.

Frequently Asked Questions

Is ketamine therapy safe for everyone? No. Ketamine therapy is not appropriate for everyone, which is exactly why absolute contraindications exist. People with uncontrolled severe hypertension, active psychosis, aneurysmal vascular disease, or who are pregnant or breastfeeding should not receive ketamine therapy, and a proper screening process is designed to catch these cases before treatment starts.

What are the most common side effects of ketamine therapy? Most people experience transient effects like dizziness, mild nausea, and dissociation that resolve within one to two hours, according to Cleveland Clinic. Serious adverse events are uncommon in properly screened, supervised patients.

When should you avoid ketamine therapy entirely? Avoid ketamine therapy if you have uncontrolled hypertension, an aneurysm or recent brain hemorrhage, active psychosis or mania, unstable heart disease, or if you’re pregnant or breastfeeding. These are the absolute contraindications, not conditions that improve with extra monitoring.

Can you still get ketamine therapy if you have controlled high blood pressure? Often yes. Well-controlled hypertension is generally treated as a relative contraindication, meaning it requires monitoring and on-day blood pressure checks rather than automatic exclusion.

Does a history of psychosis always disqualify you? Not always. A remote, well-managed episode is typically evaluated differently from active psychosis, but it does require a formal psychiatric consultation before a clinic makes a decision.

How do clinics screen for ketamine therapy eligibility? Screening typically includes blood pressure checks, a detailed medical and psychiatric history review, baseline labs such as an ECG, liver function tests, a urine drug screen, and a pregnancy test where applicable, with specialist referrals when your history warrants it.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

Sources

For readers who want to verify the clinical claims in this article rather than take them secondhand, a few primary sources stand out. The StatPearls entry on ketamine offers a peer-reviewed clinical overview of contraindications, pharmacology, and adverse effects. The SPRAVATO prescribing information on DailyMed is the FDA-regulated label, the most authoritative document available for esketamine-specific contraindications and monitoring requirements.

• Ketamine - StatPearls - NCBI Bookshelf
• Peer-reviewed review on IV ketamine safety and use (PMC article)
• Ketamine therapy overview — Cleveland Clinic

Recommended

• Ketamine Tolerance: What It Means for Your Treatment
• Why Use Ketamine for Depression: A Clear Guide
• Step by Step Ketamine Therapy: A First-Timer’s Guide
• Clinical Evidence